Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
compounder
Pharma
Hims quits on obesity pill after legal, regulatory heat
Hims has quickly retreated from its launch of a compounded obesity pill after facing mounting pressure from the FDA and Novo Nordisk.
Fraiser Kansteiner
Feb 9, 2026 10:24am
Novo faces lawsuit over semaglutide sales projections
Aug 5, 2025 8:30am
Hims & Hers tackles high GLP-1 prices in Super Bowl ad
Jan 29, 2025 5:15am
Lilly seeks to intervene in compounded tirzepatide lawsuit
Jan 2, 2025 4:16pm
